Zepp Health Operating Margin 2017-2025 | ZEPP
Current and historical operating margin for Zepp Health (ZEPP) over the last 10 years. The current operating profit margin for Zepp Health as of September 30, 2025 is -21.53%.
| Zepp Health Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.23B | $-0.03B | -14.53% |
| 2025-06-30 | $0.20B | $-0.05B | -23.00% |
| 2025-03-31 | $0.18B | $-0.05B | -27.47% |
| 2024-12-31 | $0.18B | $-0.05B | -26.23% |
| 2024-09-30 | $0.21B | $-0.04B | -18.45% |
| 2024-06-30 | $0.25B | $-0.02B | -9.72% |
| 2024-03-31 | $0.30B | $-0.02B | -8.05% |
| 2023-12-31 | $0.35B | $-0.03B | -8.52% |
| 2023-09-30 | $0.42B | $-0.04B | -9.40% |
| 2023-06-30 | $0.50B | $-0.05B | -9.96% |
| 2023-03-31 | $0.58B | $-0.06B | -9.91% |
| 2022-12-31 | $0.60B | $-0.06B | -10.00% |
| 2022-09-30 | $0.70B | $-0.04B | -5.97% |
| 2022-06-30 | $0.82B | $-0.02B | -2.57% |
| 2022-03-31 | $0.83B | $-0.01B | -1.45% |
| 2021-09-30 | $1.05B | $0.02B | 2.29% |
| 2021-06-30 | $1.13B | $0.03B | 2.30% |
| 2021-03-31 | $1.01B | $0.02B | 1.59% |
| 2020-12-31 | $0.99B | $0.03B | 2.74% |
| 2020-09-30 | $0.95B | $0.05B | 4.96% |
| 2020-06-30 | $0.88B | $0.07B | 7.50% |
| 2020-03-31 | $0.87B | $0.08B | 8.97% |
| 2019-12-31 | $0.84B | $0.09B | 10.42% |
| 2019-09-30 | $0.70B | $0.07B | 10.63% |
| 2019-06-30 | $0.59B | $0.06B | 10.32% |
| 2019-03-31 | $0.56B | $0.06B | 11.35% |
| 2018-12-31 | $0.53B | $0.05B | 9.83% |
| 2018-09-30 | $0.48B | $0.15B | 31.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.338B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |